Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B.

Schlenk, Richard F

Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B. [electronic resource] - Haematologica Jan 2009 - 54-60 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1592-8721

10.3324/haematol.13378 doi


Aged
Aged, 80 and over
Biomarkers--metabolism
Disease-Free Survival
Female
Humans
Leukemia, Myeloid, Acute--drug therapy
Male
Middle Aged
Mutation--genetics
Nucleophosmin
Pilot Projects
Survival Rate
Treatment Outcome
Tretinoin--therapeutic use